Reports for HIKMA CANADA LIMITED

Company Name

HIKMA CANADA LIMITED

Totals

Shortage reports

82

Actual shortage: 12 (15%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (1%)
Resolved: 69 (84%)

Discontinuation Reports

4

To be discontinued: 3 (75%)
Discontinued: 1 (25%)
Reversed: 0 (0%)

Late reports

16 (19%)

Overdue reports

10 (67%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATROPINE INJECTION BP 0.6MG SOLUTION Resolved 2023-11-17 2024-04-17 210691
ENALAPRILAT INJECTION USP 1.25MG SOLUTION Actual shortage 2023-12-19 2024-03-01 213843

Showing 81 to 82 of 82

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165188
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.375G 3G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165193
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 0.5G 4G POWDER FOR SOLUTION To be discontinued 2022-07-21 2022-07-21 165196
LIDOCAINE HYDROCHLORIDE INJECTION USP 10MG SOLUTION Discontinued 2024-04-19 2024-04-22 225805

Showing 1 to 4 of 4